Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients

British Journal of Cancer

Volumn 106, Issue 12, 2012, Pages 2004-2009

  Felix, A S ^a   Edwards, R P ^b   Stone, R A ^c   Chivukula, M ^b   Parwani, A V ^d   Bowser, R ^d   Linkov, F ^c,e   Weissfeld, J L ^c,e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

angiogenesis; growth factors; prognostic biomarkers; recurrence free survival; stroma

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; COHORT ANALYSIS; DISEASE SEVERITY; ENDOMETRIUM CANCER; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; RECURRENCE RISK;

AGED; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPATOCYTE GROWTH FACTOR; HUMANS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84862026119     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.200     Document Type: Article

References (31)

1. Albini A, Sporn MB (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7(2): 139-147 (Pubitemid 46160989)
2. Alshenawy HA (2010) Prognostic significance of vascular endothelial growth factor, basic fibroblastic growth factor, and microvessel density and their relation to cell proliferation in B-cell non-Hodgkin's lymphoma. Ann Diagn Pathol 14(5): 321-327
3. Andersen S, Donnem T, Al-Saad S, Al-Shibli K, Busund LT, Bremnes RM (2009) Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy. J Thorac Oncol 4(4): 463-471
4. Behrens C, Lin HY, Lee JJ, Raso MG, Hong WK, Wistuba II, Lotan R (2008) Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clin Cancer Res 14(19): 6014-6022
5. Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4(12): 915-925 (Pubitemid 37493640)
6. Bishop EA, Lengyel ER, Yamada SD, Montag A, Temkin SM (2011) The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma. Gynecol Oncol 121(1): 218-223
7. Chung AS, Lee J, Ferrara N (2010) Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10(7): 505-514
8. Comoglio PM, Giordano S, Trusolino L (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7(6): 504-516 (Pubitemid 351767118)
9. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4): 429-447 (Pubitemid 36818244)
10. Donnem T, Al-Saad S, Al-Shibli K, Delghandi MP, Persson M, Nilsen MN, Busund LT, Bremnes RM (2007) Inverse prognostic impact of angiogenic marker expression in tumor cells vs stromal cells in non small cell lung cancer. Clin Cancer Res 13(22 Part 1): 6649-6657 (Pubitemid 350206800)
11. Faridi A, Rudlowski C, Biesterfeld S, Schuh S, Rath W, Schroder W (2002) Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer. Pathol Res Pract 198(1): 1-5 (Pubitemid 34163122)
12. Felix AS, Weissfeld JL, Stone RA, Bowser R, Chivukula M, Edwards RP, Linkov F (2010) Factors associated with type I and type II endometrial cancer. Cancer Causes Control 21(11): 1851-1856
13. Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16): 15-18
14. Fujimoto J, Hori M, Ichigo S, Tamaya T (1995) Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Invasion Metastasis 15(5-6): 203-210 (Pubitemid 26290095)
15. Gordon MS, Sweeney CS, Mendelson DS, Eckhardt SG, Anderson A, Beaupre DM, Branstetter D, Burgess TL, Coxon A, Deng H, Kaplan-Lefko P, Leitch IM, Oliner KS, Yan L, Zhu M, Gore L (2010) Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-inhuman study of patients with advanced solid tumors. Clin Cancer Res 16(2): 699-710
16. Guddo F, Fontanini G, Reina C, Vignola AM, Angeletti A, Bonsignore G (1999) The expression of basic fibroblast growth factor (bFGF) in tumorassociated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression. Hum Pathol 30(7): 788-794 (Pubitemid 29325785)
17. Hamilton CA, Cheung MK, Osann K, Chen L, Teng NN, Longacre TA, Powell MA, Hendrickson MR, Kapp DS, Chan JK (2006) Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer 94(5): 642-646 (Pubitemid 43361894)
18. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5): 646-674
19. Hiscox S, Barrett-Lee P, Nicholson RI (2011) Therapeutic targeting of tumor-stroma interactions. Expert Opin Ther Targets 15(5): 609-621
20. Joyce JA (2005) Therapeutic targeting of the tumor microenvironment. Cancer Cell 7(6): 513-520 (Pubitemid 40799245)
21. Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4): 239-252
22. Lieu C, Heymach J, Overman M, Tran H, Kopetz S (2011) Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis. Clin Cancer Res 17(19): 6130-6139
23. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y (1997) Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 57(15): 3305-3313 (Pubitemid 27351751)
24. Rosen EM, Joseph A, Jin L, Rockwell S, Elias JA, Knesel J, Wines J,McClellan J, Kluger MJ, Goldberg ID, Zitnik R (1994) Regulation of scatter factor production via a soluble inducing factor. J Cell Biol 127(1): 225-234 (Pubitemid 24307669)
25. Stefansson IM, Salvesen HB, Akslen LA (2006) Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 66(6): 3303-3309
26. Strohmeyer D, Strauss F, Rossing C, Roberts C, Kaufmann O, Bartsch G, Effert P (2004) Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma. Anticancer Res 24(3a): 1797-1804 (Pubitemid 38954712)
27. Takanami I, Tanaka F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, Kodaira S (1996) The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: an investigation of their expression as prognostic markers. Eur J Cancer 32A(9): 1504-1509 (Pubitemid 26279115)
28. Wagatsuma S, Konno R, Sato S, Yajima A (1998) Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. Cancer 82(3): 520-530 (Pubitemid 28112991)
29. Yamazaki K, Nagao T, Yamaguchi T, Saisho H, Kondo Y (1997) Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma. Virchows Arch 431(2): 95-101 (Pubitemid 27393839)
30. Yap TA, de Bono JS (2010) Targeting the HGF/c-Met Axis: State of Play. Mol Cancer Ther 9(5): 1077-1079
31. Yoshida S, Harada T, Iwabe T, Taniguchi F, Fujii A, Sakamoto Y Yamauchi N, Shiota G, Terakawa N (2002) Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer. J Clin Endocrinol Metab 87(5): 2376-2383 (Pubitemid 34521533)